Thuja Capital Healthcare Fund II is backed by a number of investors that do not only provide capital to the fund, but also bring a valuable network:
- Rabobank: The Rabobank is major Dutch bank and an important financier in the Dutch healthcare sector. Through its investment held by Rabo Private Equity in Thuja Capital Healthcare Fund II, Rabobank wants to contribute to healthcare innovations that are beneficial to both citizens as well as society. Because of its deep involvement in the Dutch healthcare sector Thuja Capital can benefit from the many contacts of Rabobank and its understanding of the developments in the sector.
- Utrecht Holdings: Utrecht University and University Medical Center Utrecht have a joint technology transfer office, Utrecht Holdings. It is focused on the transfer, utilization and commercialization of academic research. Since 1996 it has been supporting scientists in creating, building and investing in innovations with a particular expertise in biotech, medtech, education and ICT. They have established over 40 spin-off companies and invested over € 15 million in these new ventures. Utrecht Holdings and Thuja Capital have been successfully working together since 2008.
- Radboud Valorization: The technology transfer office of Radboud University Medical Center (Radboudumc), Department Valorization, is deeply involved, amongst others, in evaluation, patenting and commercialization of new technologies. The department negotiates licenses and facilitates the process of spinning off new companies. Radboudumc Holding B.V. has 19 spin-off companies in which 153 FTE are employed, and in which to date EUR 44M has been invested. On average 15 new patent applications are filed annually.